BioMedSA’s Board of Directors approved 5 new memberships in November 2025: BleedIO, ClearCam, DIRTT, Julie Riegel and QRx Partners.
BleedIO delivers SaaS and HaaS solutions using BLE Mesh, a wireless technology designed for decentralized networks that operate without internet or centralized systems. Proprietary technology improves uptime, resiliency, and security for IoT. Device-to-device (D2D) communication enables scalable, portable networks. For example, BLE Mesh supports relative positioning and inter-drone communication through standard BLE beacons, providing a robust framework for decentralized connectivity.
ClearCam specializes in solutions for laparoscopic surgery visualization. The flagship product, ClearScope, is a disposable device that in intended to clean the laparoscope lens in real time inside the patient, eliminating the need to remove the scope. This in-vivo cleaning mechanism improves clarity and continuous vision during minimally invasive procedures, reducing interruptions, shortening procedure times, and enhancing surgical safety.
DIRTT construction systems provide design flexibility for creating functional spaces. Durable components combined with intuitive technology enable custom modular interiors delivered faster, cleaner, and more sustainably, without unexpected costs or delays. Precision manufacturing and rapid installation ensure adaptability and long-term value while protecting initial investment. Built for today and prepared for tomorrow.
Community Member Julie Riegel works with RNA therapeutics focusing on rare diseases and cardiology. Current work involves serving as Associate Director within Clinical Operations for the myotonic dystrophy type 1 (DM1) Phase 3 global trial. Responsibilities include oversight of trial execution, compliance, and operational strategy to advance therapeutic development. Experience spans more than 20 years in the industry, contributing to clinical research and development across therapeutic areas.
QRx Partners is a regulatory and quality management system (QMS) consulting firm specializing in helping Medtech companies achieve domestic and international regulatory approvals. Headquartered in Minneapolis, Minnesota, QRx Partners collaborates globally with both start-ups and established medtech organizations. Services include strategic guidance, compliance support, and implementation of regulatory frameworks to streamline approval processes and ensure adherence to industry standards. Expertise spans multiple markets, enabling efficient navigation of complex regulatory environments worldwide.